Fields of Interest

Patients with hematological disease face the burden of their disease and treatments which may cause substantial suffering (symptoms and side effects) and a negative impact on quality of life. The maintenance of patients’ well-being is a fundamental goal of medical practice, and it is of crucial importance in the care of patients with hematological disease. A concern in treatment of hematological disease is disease- and treatment related symptom burden which is often underestimated in research and in routine hematological practice. Associazione QOL-ONE promotes international research to evaluate patient-reported outcomes as a fundamental endpoint both in observational and in clinical trials.